Literature DB >> 17950772

Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.

Courtney G Woods1, Oksana Kosyk, Blair U Bradford, Pamela K Ross, Amanda M Burns, Michael L Cunningham, Pingping Qu, Joseph G Ibrahim, Ivan Rusyn.   

Abstract

Administration of peroxisome proliferators to rodents causes proliferation of peroxisomes, induction of beta-oxidation enzymes, hepatocellular hypertrophy and hyperplasia, with chronic exposure ultimately leading to hepatocellular carcinomas. Many responses associated with peroxisome proliferators are nuclear receptor-mediated events involving peroxisome proliferators-activated receptor alpha (PPARalpha). A role for nuclear receptor-independent events has also been shown, with evidence of Kupffer cell-mediated free radical production, presumably through NAPDH oxidase, induction of redox-sensitive transcription factors involved in cytokine production and cytokine-mediated cell replication following acute treatment with peroxisome proliferators in rodents. Recent studies have demonstrated, by using p47(phox)-null mice which are deficient in NADPH oxidase, that this enzyme is not related to the phenotypic events caused by prolonged administration of peroxisome proliferators. In an effort to determine the timing of the transition from Kupffer cell-to PPARalpha-dependent modulation of peroxisome proliferator effects, gene expression was assessed in liver from Pparalpha-null, p47(phox)-null and corresponding wild-type mice following treatment with 4-chloro-6-(2,3-xylidino)-pyrimidynylthioacetic acid (WY-14,643) for 8 h, 24 h, 72 h, 1 week or 4 weeks. WY-14,643-induced gene expression in p47(phox)-null mouse liver differed substantially from wild-type mice at acute doses and striking differences in baseline expression of immune related genes were evident. Pathway mapping of genes that respond to WY-14,643 in a time- and dose-dependent manner demonstrates suppression of immune response, cell death and signal transduction and promotion of lipid metabolism, cell cycle and DNA repair. Furthermore, these pathways were largely dependent on PPARalpha, not NADPH oxidase demonstrating a temporal shift in response to peroxisome proliferators. Overall, this study shows that NADPH oxidase-dependent events, while detectable following acute treatment, are transient. To the contrary, a strong PPARalpha-specific gene signature was evident in mice that were continually exposed to WY-14,643.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950772      PMCID: PMC2153436          DOI: 10.1016/j.taap.2007.08.028

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  52 in total

Review 1.  Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?

Authors:  R A Roberts; N H James; S Cosulich; S C Hasmall; G Orphanides
Journal:  Toxicol Lett       Date:  2001-03-31       Impact factor: 4.372

Review 2.  Cytokines in the liver.

Authors:  G Ramadori; T Armbrust
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

3.  Pathway studio--the analysis and navigation of molecular networks.

Authors:  Alexander Nikitin; Sergei Egorov; Nikolai Daraselia; Ilya Mazo
Journal:  Bioinformatics       Date:  2003-11-01       Impact factor: 6.937

4.  Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes.

Authors:  W Parzefall; W Berger; E Kainzbauer; O Teufelhofer; R Schulte-Hermann; R G Thurman
Journal:  Carcinogenesis       Date:  2001-03       Impact factor: 4.944

5.  Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.

Authors:  Richard A Currie; Vincent Bombail; Jason D Oliver; David J Moore; Fei Ling Lim; Victoria Gwilliam; Ian Kimber; Kevin Chipman; Jonathan G Moggs; George Orphanides
Journal:  Toxicol Sci       Date:  2005-05-18       Impact factor: 4.849

6.  Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643.

Authors:  J M Peters; R C Cattley; F J Gonzalez
Journal:  Carcinogenesis       Date:  1997-11       Impact factor: 4.944

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

8.  Peroxisome proliferators activate Kupffer cells in vivo.

Authors:  H K Bojes; R G Thurman
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

9.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators.

Authors:  S S Lee; T Pineau; J Drago; E J Lee; J W Owens; D L Kroetz; P M Fernandez-Salguero; H Westphal; F J Gonzalez
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

10.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Peroxisome proliferator-activated receptors and cancer: challenges and opportunities.

Authors:  Jihan Youssef; Mostafa Badr
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 2.  Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.

Authors:  Lucía Fuentes; Tamás Roszer; Mercedes Ricote
Journal:  Mediators Inflamm       Date:  2010-05-20       Impact factor: 4.711

3.  Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.

Authors:  Pamela K Ross; Courtney G Woods; Blair U Bradford; Oksana Kosyk; Daniel M Gatti; Michael L Cunningham; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2008-12-24       Impact factor: 4.219

4.  Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.

Authors:  Hongzu Ren; Lauren M Aleksunes; Carmen Wood; Beena Vallanat; Michael H George; Curtis D Klaassen; J Christopher Corton
Journal:  Toxicol Sci       Date:  2009-10-22       Impact factor: 4.849

Review 5.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

6.  Computational toxicology: realizing the promise of the toxicity testing in the 21st century.

Authors:  Ivan Rusyn; George P Daston
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

7.  Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells.

Authors:  Danyel Jennen; Ainhoa Ruiz-Aracama; Christina Magkoufopoulou; Ad Peijnenburg; Arjen Lommen; Joost van Delft; Jos Kleinjans
Journal:  BMC Syst Biol       Date:  2011-08-31

8.  A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPARα Knockout by Gene Set Enrichment Analysis.

Authors:  Kan He; Qishan Wang; Yumei Yang; Minghui Wang; Yuchun Pan
Journal:  PPAR Res       Date:  2011-07-27       Impact factor: 4.964

9.  Toxicogenomic biomarkers for liver toxicity.

Authors:  Naoki Kiyosawa; Yosuke Ando; Sunao Manabe; Takashi Yamoto
Journal:  J Toxicol Pathol       Date:  2009-04-06       Impact factor: 1.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.